These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8070008)

  • 1. Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.
    Cortés F; Piñero J
    Cancer Chemother Pharmacol; 1994; 34(5):411-5. PubMed ID: 8070008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
    Cortés F; Piñero J; Ortiz T
    Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine.
    López-Baena M; Mateos S; Piñero J; Trinidad Ortiz ; Cortés F
    Mutat Res; 1998 Oct; 421(1):109-16. PubMed ID: 9748527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
    Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
    Darroudi F; Natarajan AT
    Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
    Kaufmann WK; Boyer JC; Estabrooks LL; Wilson SJ
    Mol Cell Biol; 1991 Jul; 11(7):3711-8. PubMed ID: 1646393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F; Piñero J; Palitti F
    Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sister chromatid exchange induced by DNA topoisomerases poisons in late replicating heterochromatin: influence of inhibition of replication and transcription.
    Piñero J; López Baena M; Ortiz T; Cortés F
    Mutat Res; 1996 Jul; 354(2):195-201. PubMed ID: 8764948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells.
    Dillehay LE; Denstman SC; Williams JR
    Cancer Res; 1987 Jan; 47(1):206-9. PubMed ID: 3024815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
    Benchokroun Y; Couprie J; Larsen AK
    Biochem Pharmacol; 1995 Jan; 49(3):305-13. PubMed ID: 7857317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
    Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
    Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Holm C; Covey JM; Kerrigan D; Pommier Y
    Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Kaufmann SH
    Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells.
    Suzuki H; Nakane S
    Biol Pharm Bull; 1994 Feb; 17(2):222-6. PubMed ID: 8205120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II.
    Caldecott K; Banks G; Jeggo P
    Cancer Res; 1990 Sep; 50(18):5778-83. PubMed ID: 2168280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
    Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
    Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
    Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
    Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.